Pulse NeedleFree Systems
Curated by SignalDeveloping needle free pharmaceutical delivery solutions for animals and humans
Overview
Pulse Needle Free Systems has developed needle-free pharmaceutical injection systems for the animal and human health industries. The company has three products (Pulse 50, Pulse 250, and Pulse 500) for the animal market which allow transdermal needle-free injection of pharmaceutical dose in the range of 0.1-5ml. The company is developing needle-free injection product, HSI-500 which utilizes a proprietary protector cap to serve as a hygienic patient interface and the company has achieved U.S. FDA clearance to market the HSI-500 system. The company is also developing needle-free delivery solutions for plants which will allow researchers to deliver inoculum of bacterial suspension to the mesophyll of citrus leaves.
Key facts
- Founded
- 2001
- Headquarters
- Lenexa, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 2 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Sign up to view
- Phone
- Sign up to view